Searched for: in-biosketch:true
person:segevd01
FRAILTY AND KIDNEY TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS [Meeting Abstract]
Quint, Evelien; Zogaj, Donika; Banning, Wiesje; Benjamens, Stan; Annema, Coby; Bakker, Stephan; Nieuwenhuijs-Moeke, Gertrude; Segev, Dorry; Mcadams-Demarco, Mara; Pol, Robert
ISI:000689725500292
ISSN: 0934-0874
CID: 5133212
Ambient Air Pollution and Mortality among Older Patients Initiating Maintenance Dialysis
Feng, Yijing; Jones, Miranda R; Chu, Nadia M; Segev, Dorry L; McAdams-DeMarco, Mara
BACKGROUND:Fine particulate matter (particulate matter with diameter <2.5 µm [PM2.5]) is associated with CKD progression and may impact the health of patients living with kidney failure. While older (aged ≥65 years) adults are most vulnerable to the impact of PM2.5, it is unclear whether older patients on dialysis are at elevated risk of mortality when exposed to fine particulate matter. METHODS:Older adults initiating dialysis (2010-2016) were identified from US Renal Data System (USRDS). PM2.5 concentrations were obtained from NASA's Socioeconomic Data and Application Center (SEDAC) Global Annual PM2.5 Grids. We investigated the association between PM2.5 and all-cause mortality using Cox proportional hazard models with linear splines [knot at the current Environmental Protection Agency (EPA) National Ambient Air Quality Standard for PM2.5 of 12 μg/m3] and robust variance. RESULTS:For older dialysis patients who resided in areas with high PM2.5, a 10 μg/m3 increase in PM2.5 was associated with 1.16-fold (95% CI: 1.08-1.25) increased risk of mortality; furthermore, those who were female (aHR = 1.26, 95% CI: 1.13-1.42), Black (aHR = 1.31, 95% CI: 1.09-1.59), or had diabetes as a primary cause of kidney failure (aHR = 1.25, 95% CI: 1.13-1.38) were most vulnerable to high PM2.5. While the mortality risk associated with PM2.5 was stronger at higher levels (aHR = 1.19, 95% CI: 1.08-1.32), at lower levels (≤12 μg/m3), PM2.5 was significantly associated with mortality risk (aHR = 1.04, 95% CI: 1.00-1.07) among patients aged ≥75 years (Pslope difference = 0.006). CONCLUSIONS:Older adults initiating dialysis who resided in ZIP codes with PM2.5 levels >12 μg/m3 are at increased risk of mortality. Those aged >75 were at elevated risk even at levels below the EPA Standard for PM2.5.
PMID: 33789279
ISSN: 1421-9670
CID: 5127082
PRE-TRANSPLANT FRAILTY IS A KEY DETERMINANT OF GLOBAL FUNCTIONAL HEALTH AFTER LIVER TRANSPLANTATION: FROM THE MULTICENTER FUNCTIONAL ASSESSMENT IN LIVER TRANSPLANTATION (FRAILT) STUDY [Meeting Abstract]
Lai, Jennifer Cindy; Shui, Amy; Rahimi, Robert S.; Ganger, Daniel R.; Verna, Elizabeth C.; Volk, Michael; Kappus, Matthew R.; Ladner, Daniela P.; Boyarsky, Brian J.; Segev, Dorry L.; Gao, Ying; Huang, Chiung-Yu; Singer, Jonathan; Duarte-Rojo, Andres
ISI:000707188004220
ISSN: 0270-9139
CID: 5133362
HEALTH DISPARITIES IN LIVER TRANSPLANT EVALUATION BY THE PATIENT'S NEIGHBORHOOD DEPRIVATION [Meeting Abstract]
Strauss, Alexandra T.; Hamilton, James P.; Levin, Scott; Malinsky, Daniel S.; Sidoti, Carolyn N.; Jackson, John; Segev, Dorry L.; Jain, Vedant S.; Gurakar, Ahmet; Purnell, Tanjala S.
ISI:000707188002045
ISSN: 0270-9139
CID: 5133352
ARTIFICIAL INTELLIGENCE: THE NEWEST MEMBER OF THE LIVER TRANSPLANT EVALUATION TEAM? [Meeting Abstract]
Strauss, Alexandra T.; Sidoti, Carolyn N.; Jain, Vedant S.; Sung, Hannah C.; Purnell, Tanjala S.; Gurses, Ayse; Gurakar, Ahmet; Jackson, John; Levan, Macey L.; Gray, Stephen H.; Hamilton, James P.; Segev, Dorry L.; Wang, Jacqueline G.; Hinson, Jeremiah; Malinsky, Daniel S.; Levin, Scott
ISI:000707188002017
ISSN: 0270-9139
CID: 5133342
LIMITED IMMUNOGENICITY OF A SINGLE DOSE OF SARS-CoV-2 MRNA VACCINE IN SOLID ORGAN TRANSPLANT RECIPIENTS [Meeting Abstract]
Boyarsky, Brian; Ou, Michael; Greenberg, Ross; Teles, Aura; Werbel, William; Avery, Robin K.; Tobian, Aaron; Massie, Allan; Segev, Dorry; Garonzik-Wang, Jacqueline
ISI:000689725500551
ISSN: 0934-0874
CID: 5133232
DYNAMIC PREDICTION OF KIDNEY GRAFT SURVIVAL WITH ARTIFICIAL INTELLIGENCE: AN INTERNATIONAL STUDY OF DEEP COHORTS OF KIDNEY RECIPIENTS [Meeting Abstract]
Raynaud, Marc; Aubert, Olivier; Reese, Peter; Kamar, Nassim; Chin, Chen-Shan; Bailly, Elodie; Ladriere, Marc; Le Quintrec, Moglie; Delahousse, Michel; Juric, Ivana; Basic-Jukic, Nikolina; Crespo, Marta; Silva Junior, Helio Tedesco; Linhares, Kamilla; de Castro, Maria Cristina Ribeiro; Gervacio, Soler Pujol; Yoo, Daniel; Empana, Jean-Philippe; Ulloa, Camilo; Akalin, Enver; Boehmig, Georg; Huang, Edmund; Glotz, Denis; Jordan, Stanley; Bentall, Andrew; Montgomery, Robert; Oberbauer, Rainer; Segev, Dorry; Friedewald, John; Legendre, Christophe; Jouven, Xavier; Lefaucheur, Carmen; Loupy, Alexandre
ISI:000689725500008
ISSN: 0934-0874
CID: 5133202
TACKLING PERSISTENT HEALTH DISPARITIES IN THE LIVER TRANSPLANT EVALUATION PROCESS: A MULTI-CENTER ANALYSIS OF PROVIDER PERSPECTIVES ON MECHANISMS AND OPPORTUNITIES TO ADVANCE EQUITY [Meeting Abstract]
Strauss, Alexandra T.; Sidoti, Carolyn N.; Jain, Vedant S.; Sung, Hannah C.; Gurses, Ayse; Jackson, John; Levan, Macey L.; Levin, Scott; Gray, Stephen H.; Segev, Dorry L.; Gurakar, Ahmet; Wang, Jacqueline G.; Hamilton, James P.; Purnell, Tanjala S.
ISI:000707188000179
ISSN: 0270-9139
CID: 5133332
EARLY SAFETY OF SARS-CoV-2 MRNA VACCINES IN SOLID ORGAN TRANSPLANT RECIPIENTS [Meeting Abstract]
Ou, Michael; Boyarsky, Brian; Motter, Jennifer; Greenberg, Ross; Teles, Aura; Ruddy, Jake; Krach, Michelle; Werbel, William; Avery, Robin K.; Massie, Allan; Segev, Dorry; Garonzik-Wang, Jacqueline
ISI:000689725500549
ISSN: 0934-0874
CID: 5133222
The Tangible Benefits of Living Donation: Results of a Qualitative Study of Living Kidney Donors
Van Pilsum Rasmussen, Sarah E; Robin, Miriam; Saha, Amrita; Eno, Anne; Lifshitz, Romi; Waldram, Madeleine M; Getsin, Samantha N; Chu, Nadia M; Al Ammary, Fawaz; Segev, Dorry L; Henderson, Macey L
The framework currently used for living kidney donor selection is based on estimation of acceptable donor risk, under the premise that benefits are only experienced by the recipient. However, some interdependent donors might experience tangible benefits from donation that cannot be considered in the current framework (ie, benefits experienced directly by the donor that improve their daily life, well-being, or livelihood).
PMCID:7665258
PMID: 33204824
ISSN: 2373-8731
CID: 5126802